» Articles » PMID: 33586462

Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study

Overview
Date 2021 Feb 15
PMID 33586462
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Background Elevated plasma levels of direct low-density lipoprotein cholesterol (LDL-C), small dense LDL-C (sdLDL-C), low-density lipoprotein (LDL) triglycerides, triglycerides, triglyceride-rich lipoprotein cholesterol, remnant lipoprotein particle cholesterol, and lipoprotein(a) have all been associated with incident atherosclerotic cardiovascular disease (ASCVD). Our goal was to assess which parameters were most strongly associated with ASCVD risk. Methods and Results Plasma total cholesterol, triglycerides, high-density lipoprotein cholesterol, direct LDL-C, sdLDL-C, LDL triglycerides, remnant lipoprotein particle cholesterol, triglyceride-rich lipoprotein cholesterol, and lipoprotein(a) were measured using standardized automated analysis (coefficients of variation, <5.0%) in samples from 3094 fasting subjects free of ASCVD. Of these subjects, 20.2% developed ASCVD over 16 years. On univariate analysis, all ASCVD risk factors were significantly associated with incident ASCVD, as well as the following specialized lipoprotein parameters: sdLDL-C, LDL triglycerides, triglycerides, triglyceride-rich lipoprotein cholesterol, remnant lipoprotein particle cholesterol, and direct LDL-C. Only sdLDL-C, direct LDL-C, and lipoprotein(a) were significant on multivariate analysis and net reclassification after adjustment for standard risk factors (age, sex, hypertension, diabetes mellitus, smoking, total cholesterol, and high-density lipoprotein cholesterol). Using the pooled cohort equation, many specialized lipoprotein parameters individually added significant information, but no parameter added significant information once sdLDL-C (hazard ratio, 1.42; <0.0001) was in the model. These results for sdLDL-C were confirmed by adjusted discordance analysis versus calculated non-high-density lipoprotein cholesterol, in contrast to LDL triglycerides. Conclusions sdLDL-C, direct LDL-C, and lipoprotein(a) all contributed significantly to ASCVD risk on multivariate analysis, but no parameter added significant risk information to the pooled cohort equation once sdLDL-C was in the model. Our data indicate that small dense LDL is the most atherogenic lipoprotein parameter.

Citing Articles

Association of estimated small dense low-density lipoprotein cholesterol with diabetes mellitus: a large-scale multicenter retrospective cohort study.

Gao Y BMC Endocr Disord. 2025; 25(1):66.

PMID: 40065380 PMC: 11895197. DOI: 10.1186/s12902-025-01880-w.


Practical Approaches to Managing Dyslipidemia in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

Bril F, Berg G, Barchuk M, Nogueira J J Lipid Atheroscler. 2025; 14(1):5-29.

PMID: 39911965 PMC: 11791423. DOI: 10.12997/jla.2025.14.1.5.


Saturated fat in an evolutionary context.

Garnas E Lipids Health Dis. 2025; 24(1):28.

PMID: 39875911 PMC: 11773866. DOI: 10.1186/s12944-024-02399-0.


Atherogenic index of plasma and cardiovascular outcomes in female patients undergoing percutaneous coronary intervention: insights from a retrospective cohort study.

Jiang Y Sci Rep. 2025; 15(1):3112.

PMID: 39856112 PMC: 11760380. DOI: 10.1038/s41598-025-87281-4.


Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational study.

Ikezaki H, Nakashima R, Matsumoto Y, Ohta A, Yamasaki S, Hiramine S Atheroscler Plus. 2025; 59():10-17.

PMID: 39802653 PMC: 11719292. DOI: 10.1016/j.athplu.2024.12.003.


References
1.
Kannel W, Feinleib M, MCNAMARA P, Garrison R, CASTELLI W . An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979; 110(3):281-90. DOI: 10.1093/oxfordjournals.aje.a112813. View

2.
Okada M, Matsui H, Ito Y, Fujiwara A, Inano K . Low-density lipoprotein cholesterol can be chemically measured: a new superior method. J Lab Clin Med. 1998; 132(3):195-201. DOI: 10.1016/s0022-2143(98)90168-8. View

3.
Sakaue T, Hirano T, Yoshino G, Sakai K, Takeuchi H, Adachi M . Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: comparison of three homogeneous methods. Clin Chim Acta. 2000; 295(1-2):97-106. DOI: 10.1016/s0009-8981(00)00200-x. View

4.
Nishikura T, Koba S, Yokota Y, Hirano T, Tsunoda F, Shoji M . Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease. J Atheroscler Thromb. 2014; 21(8):755-67. DOI: 10.5551/jat.23465. View

5.
Hirano T, Ito Y, Koba S, Toyoda M, Ikejiri A, Saegusa H . Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol. 2004; 24(3):558-63. DOI: 10.1161/01.ATV.0000117179.92263.08. View